BlackRock, Inc. 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-17 7:54 pm Purchase |
2025-06-30 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
BlackRock Inc. BLK |
5,849,917 5.800% |
1,037,610 (+21.56%) |
Filing |
| 2025-04-28 5:45 pm Sale |
2025-03-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
BlackRock Inc. BLK |
4,812,307 4.700% |
-313,764 (-6.12%) |
Filing |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
BlackRock Inc. BLK |
5,126,071 5.900% |
5,126,071 (New Position) |
Filing |